Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
S2Medical ABOSTO:S2M Cyclically Adjusted PS Ratio is 0.06 as of Jul. 31, 2026, which is 33% below its 10-year median of 0.09. The stock has 3 warning signs investors should review. Among 520 Medical Devices & Instruments companies, S2Medical AB ranks better than 97.31% on this metric.
The historical rank and industry rank for S2Medical AB's Cyclically Adjusted PS Ratio or its related term are showing as below:
OSTO:S2M'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.06 Med: 0.09 Max: 0.13
Current: 0.06
During the past 10 years, S2Medical AB's highest Cyclically Adjusted PS Ratio was 0.13. The lowest was 0.06. And the median was 0.09.
OSTO:S2M's Cyclically Adjusted PS Ratio is ranked better than 97.31% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 2.26
vs OSTO:S2M: 0.06
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
S2Medical AB's adjusted revenue per share data of for the fiscal year that ended in Dec25 was kr0.017. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr0.09 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
S2Medical AB (OSTO:S2M) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
S2Medical AB Cyclically Adjusted PS Ratio Related Terms
S2Medical AB Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for S2Medical AB's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:S2M vs ISRG, BDX, MDLN: Cyclically Adjusted PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, S2Medical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where S2Medical AB's Cyclically Adjusted PS Ratio falls into.
S2Medical AB Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
S2Medical AB's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.06 mean?
S2Medical AB (OSTO:S2M) has a Cyclically Adjusted PS Ratio of 0.06 as of Jul. 31, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on S2Medical AB and its competitors. This is 33% below median its historical median of 0.09. Over the past decade, S2Medical AB's Cyclically Adjusted PS Ratio has ranged from 0.06 to 0.13. According to the industry distribution chart, S2Medical AB ranks #14 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 2.7%.
Is S2Medical AB's Cyclically Adjusted PS Ratio too high?
S2Medical AB's current Cyclically Adjusted PS Ratio of 0.06 is 33% below median its 10-year median of 0.09. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.13. The Medical Devices & Instruments industry median Cyclically Adjusted PS Ratio is 2.26. S2Medical AB's value of 0.06 is 97.3% below this industry median. Based on the distribution chart, S2Medical AB ranks #14 out of 520 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does S2Medical AB's Cyclically Adjusted PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #14 out of 520 companies for Cyclically Adjusted PS Ratio. This places S2Medical AB in the top 3% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PS Ratio is 2.26. S2Medical AB's value of 0.06 is 97.3% below this benchmark. Historically, S2Medical AB's own Cyclically Adjusted PS Ratio has ranged from 0.06 to 0.13 over the past decade. While the company's 10-year median is 0.09 vs. the industry median of 2.26, S2Medical AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PS Ratio among Medical Devices & Instruments companies is 2.26, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. S2Medical AB's current Cyclically Adjusted PS Ratio of 0.06 is 97.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on S2Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PS Ratio is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current Cyclically Adjusted PS Ratio is 0.06, which is 33% below median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
Based on GuruFocus' analysis, S2Medical AB (OSTO:S2M) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.01, compared to a current price of kr0.01 — trading 46% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.06, which is 33% below median its 10-year median of 0.09 and 97.3% below the Medical Devices & Instruments industry median of 2.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For S2Medical AB (OSTO:S2M), the current Cyclically Adjusted PS Ratio is 0.06 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:S2M has been successfully added to your 
